Gene: SLC6A9
Official Full Name: solute carrier family 6 member 9provided by HGNC
Gene Summary: The amino acid glycine acts as an inhibitory neurotransmitter in the central nervous system. The protein encoded by this gene is one of two transporters that stop glycine signaling by removing it from the synaptic cleft. [provided by RefSeq, Jun 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO04556 | SLC6A9 Knockout cell line (HeLa) | Human | SLC6A9 | 1:3~1:6 | Negative | Online Inquiry |
KO04557 | SLC6A9 Knockout cell line (HCT 116) | Human | SLC6A9 | 1:2~1:4 | Negative | Online Inquiry |
KO04558 | SLC6A9 Knockout cell line (HEK293) | Human | SLC6A9 | 1:3~1:6 | Negative | Online Inquiry |
KO04559 | SLC6A9 Knockout cell line (A549) | Human | SLC6A9 | 1:3~1:4 | Negative | Online Inquiry |
SLC6A9 Gene Knockout Cell Lines are genetically modified cell lines designed to lack the expression of the SLC6A9 gene, which encodes a sodium-dependent neurotransmitter transporter associated with the uptake of glycine and other amino acids in the central nervous system. This gene plays a crucial role in modulating excitatory and inhibitory neurotransmission, thus directly influencing synaptic plasticity and neurotransmission density.
The primary function of these knockout cell lines involves elucidating the physiological and pathological roles of the SLC6A9 gene, allowing researchers to study the resultant cellular and molecular mechanisms following gene disruption. By eliminating the SLC6A9 gene, scientists can investigate its contribution to various neurodegenerative diseases, psychiatric disorders, and the pharmacodynamics of glycine receptor-targeting compounds, thereby providing insight into potential therapeutic paths.
The scientific significance of SLC6A9 Gene Knockout Cell Lines lies in their application across diverse research and clinical contexts. They serve as vital tools in drug discovery, allowing for high-throughput screening of compounds that interact with the glycine neurotransmitter system. Furthermore, these cell lines can be instrumental in studying the underlying mechanisms of diseases, paving the way for novel therapeutic strategies.
What sets SLC6A9 Gene Knockout Cell Lines apart from alternative models, such as wild-type or overexpressing systems, is their ability to simulate a more physiologically relevant environment. By providing a clearer picture of the absence of SLC6A9 activity, these cell lines facilitate more accurate interpretation of experimental results, thereby enhancing the reproducibility of research findings.
For researchers and clinicians focused on neurobiology and pharmacology, the SLC6A9 Gene Knockout Cell Lines offer a unique opportunity to advance scientific understanding and therapeutic development in a rapidly evolving field. Our company specializes in providing high-quality, rigorously validated biological products, ensuring that our clients have access to reliable tools necessary for groundbreaking research and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.